Back to 
CANTOR FITZGERALD, L. P.
CANTOR FITZGERALD, L. P.
ARQTShowing 0 of 4 quarters
Position history for CANTOR FITZGERALD, L. P.'s holdings in ARCUTIS BIOTHERAPEUTICS INC
No. Cantor Fitzgerald exited its ARQT (Arcutis Biotherapeutics) position in Q1 2024. Its Q4 2023 13F listed 10,114 shares worth $32,668. Cantor Fitzgerald first reported ARQT in Q2 2023 and held it in 2 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ARQT: BlackRock, Inc., JENNISON ASSOCIATES LLC, FMR LLC